- •Women may be divided into ‘low to moderate’ and ‘high’ risk for breast cancer categories.
- •An individualized approach towards screening should be instigated.
- •In the ‘low to moderate’ risk category further mammography screening should be discussed.
- •In the ‘low to moderate’ risk category there is no agreement about the screening interval.
- •In high risk women yearly digital mammography, ultrasound and clinical examination is warranted.
Materials and methods
Results and conclusion
2. Publicly organized population mammography screening
2.1 Screening: advantages, limitations and risks
- Berry D.A.
- Kopans D.B.
- Webb M.L.
- Cady B.
- Weedon-Fekjær H.
- Romundstad P.R.
- Vatten L.J.
- American Cancer Society
- Miller A.B.
- Wall C.
- Baines C.J.
- Sun P.
- To T.
- Narod S.A.
- Johns L.E.
- Moss S.M.
Randomized controlled trial of mammographic screening from age 40 (‘Age’ trial): patterns of screening attendance.
- Miller A.B.
- Wall C.
- Baines C.J.
- Sun P.
- To T.
- Narod S.A.
2.2 Risk factors for breast cancer and screening
- Onega T.
- Beaber E.F.
- Sprague B.L.
- et al.
2.3 Improving population screening
3. Principles of individualized breast cancer screening
- •As most western societies have invested in public breast cancer screening programmes from age 50 for average risk women, individual screening should begin from the age at which the breast cancer risk is equal to that for an average risk women aged 50 years (≈2% in the next 10 years or remaining lifetime risk ≈8%).
- •Individual screening should stop when the risk of co-mortality from other diseases exceeds the risk of breast cancer mortality.
- •The frequency of screening rounds should be adapted to the individual level of risk.
- •Imaging modality should be adapted to breast characteristics in order to reach the best sensitivity and specificity.
- •The screening strategy should be regularly and individually reassessed.
4. Identifying women at higher risk
- Boyd N.F.
- Guo H.
- Martin L.J.
- et al.
- Hovhannisyan G.
- Chow L.
- Schlosser A.
- Yaffe M.J.
- Boyd N.F.
- Martin L.J.
5. Proposed algorithm
Provenance and peer review
- Anti-invasive/anti-metastasis strategies: new roads, new tolls and new hopes.Curr Cancer Drug Targets. 2006; 6: 729-751
- Effects of menopausal hormonal therapy on occult breast tumors.J Steroid Biochem Mol Biol. 2013; 137: 150-156
- Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011.Ann Oncol. 2011; 22: 1736-1747
- Screening for breast cancer with mammography.CDS Rev. 2011; : CD001877
- Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data.Br Med J. 2011; 343: 1-8
- Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991.Breast Cancer Res Treat. 2012; 131: 949-955
- Pitfalls in using case–control studies for the evaluation of the effectiveness of breast screening programmes.Eur J Cancer Prev. 2013; 22: 391-397
- Failure of researchers, reviewers, editors, and the media to understand flaws in cancer screening studies: application to an article in cancer.Cancer. 2014; (PubMed PMID: 24925345 [Epub ahead of print])https://doi.org/10.1002/cncr.28795
- The 20-year effort to reduce access to mammography screening: historical facts dispute a commentary in Cancer.Cancer. 2014; (PubMed PMID: 24925233 [Epub ahead of print])https://doi.org/10.1002/cncr.28791
- Breast cancer diagnosis and death in the Netherlands: a changing burden.Eur J Public Health. 2014; (pii: cku088 PubMed PMID: 24972595 [Epub ahead of print])
- Modern mammography screening and breast cancer mortality: population study.Br Med J. 2014; 348 (PMCID: PMC4061379): g3701https://doi.org/10.1136/bmj.g3701
- Global cancer facts and figures.2008http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-027766.pdf
- Survival of women with breast cancer in central and northern Denmark, 1998–2009.Clin Epidemiol. 2011; 3: 35-40
- Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.Br Med J. 2011; 343: d4411
- Screening for breast cancer with mammography.CDS Rev. 2013; 6 (PubMed PMID: 23737396): CD001877https://doi.org/10.1002/14651858.CD001877.pub5
- Randomisation by cluster and the problem of social class bias.J Epidemiol Community Health. 1989; 43: 29-36
- Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.Br Med J. 1988; 297: 943-948
- Long-term effects of mammography screening: updated overview of the Swedish randomised trials.Lancet. 2002; 359: 909-919
- Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.Radiology. 2011; 260: 658-663
- Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening.Natl Cancer Inst Monogr. 1985; 67: 65-74
- Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.Br Med J. 2014; 348: g366https://doi.org/10.1136/bmj.g366
- Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial.Breast Cancer Res Treat. 1997; 45: 263-270
- Randomized controlled trial of mammographic screening from age 40 (‘Age’ trial): patterns of screening attendance.J Med Screen. 2010; 17: 37-43https://doi.org/10.1258/jms.2010.009091
- Screening for breast cancer: worries about its effectiveness.Rev Prat. 2013; 63: 1369-1377
- Mammographic screening detects low-risk tumor biology breast cancers.Breast Cancer Res Treat. 2014; 144: 103-111
- Lead-time models should not be used to estimate overdiagnosis in cancer screening.J Gen Intern Med. 2014; ([Epub ahead of print])
- The benefits and harms of breast cancer screening: an independent review.Lancet. 2012; 380: 1778-1786
- The benefits and harms of breast cancer screening.Lancet. 2013; 381: 799
- Quantifying the benefits and harms of screening mammography.J Am Med Assoc. 2014; 174: 448-454
Belgian Cancer Registry. http://www.kankerregister.org/ [accessed 28.08.14].
- Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.Ann Intern Med. 2011; 155: 10-20
- Enhanced biological effectiveness of low energy X-rays and implications for the UK breast cancer screening programme.Br J Radiol. 2006; 79: 195-200
- The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50–69 years is minimal.Acta Radiol. 2013; (pii: 0284185113514051. [Epub ahead of print])
- Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.Cancer. 2014; ([Epub ahead of print])https://doi.org/10.1002/cncr.28771
- Should we individualize breast cancer screening?.Maturitas. 2012; 73: 202-205
- A systematic assessment of benefits and risks to guide breast cancer screening decisions.J Am Med Assoc. 2014; 311 (PubMed PMID: 24691608): 1327-1335https://doi.org/10.1001/jama.2014.1398
- Breast density and outcome of mammography screening: a cohort study.Br J Cancer. 2009; 100: 1205-1208
- The relationship of mammographic density and age: implications for breast cancer screening.Am J Roentgenol. 2012; 198: 292-295
- Breast cancer risk by breast density, age, menopause, and postmenopausal hormone therapy use.J Clin Oncol. 2010; 28: 3830-3837
- Mammographic density and the risk and detection of breast cancer.N Engl J Med. 2007; 356: 227-236https://doi.org/10.1056/NEJMoa062790
- Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.Int J Cancer. 2005; 114: 448-454
- Breast cancer risk in postmenopausal women using estradiol-progestogen therapy.Obstet Gynecol. 2009; 113: 65-73
- Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.Lancet Oncol. 2012; 13: 476-486
- Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.J Natl Cancer Inst. 2011; 103: 1179-1189
- Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.Breast Cancer Res. 2005; 7: R93-R100
- Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.Ann Intern Med. 2012; 156: 635-648
- Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.Lancet Oncol. 2010; 11: 1127-1134
- Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.Cancer. 2012; 118: 2021-2030
- Diagnostic performance of digital versus film mammography for breast-cancer screening.N Engl J Med. 2005; 353: 1773-1783
- Differences in measured mammographic density in the menstrual cycle.Cancer Epidemiol Biomarkers Prev. 2009; 18: 1993-1999https://doi.org/10.1158/1055-9965.EPI-09-0074
- Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.Eur J Cancer. 2011; 47: 1021-1026
- Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.J Am Med Assoc. 2012; 307: 1394-1404
- Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue: a systematic review.BMC Cancer. 2009; 9: 335
- MRI for breast cancer screening, diagnosis, and treatment.Lancet. 2011; 378: 1804-1811
- Familial breast cancer: Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer.June 2013 ([accessed 21.08.14])
American College of Radiology BI-RADS® – Mammography 2013. http://www.acr.org/Quality-Safety/Resources/BIRADS/Mammography [accessed 27.08.14].
- Informed choice in mammography screening.Arch Intern Med. 2007; 167: 2039-2046